000 01307 a2200361 4500
005 20250513113405.0
264 0 _c19970403
008 199704s 0 0 eng d
022 _a0093-7754
040 _aNLM
_beng
_cNLM
100 1 _aJohnson, D H
245 0 0 _aPaclitaxel, 5-fluorouracil, and folinic acid in metastatic breast cancer: BRE-26, a phase II trial.
_h[electronic resource]
260 _bSeminars in oncology
_cFeb 1997
300 _aS22-5 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aFatigue
_xchemically induced
650 0 4 _aFemale
650 0 4 _aFluorouracil
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aLeucovorin
_xadministration & dosage
650 0 4 _aMiddle Aged
650 0 4 _aMucous Membrane
_xdrug effects
650 0 4 _aNeoplasm Metastasis
650 0 4 _aNervous System Diseases
_xchemically induced
650 0 4 _aPaclitaxel
_xadministration & dosage
700 1 _aPaul, D
700 1 _aHande, K R
773 0 _tSeminars in oncology
_gvol. 24
_gno. 1 Suppl 3
_gp. S22-5
999 _c9058607
_d9058607